Matches in Wikidata for { <http://www.wikidata.org/entity/Q93078400> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q93078400 description "article scientifique publié en 2018" @default.
- Q93078400 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q93078400 description "scientific article published on 26 October 2018" @default.
- Q93078400 description "wetenschappelijk artikel" @default.
- Q93078400 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q93078400 name "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 name "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 type Item @default.
- Q93078400 label "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 label "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 prefLabel "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 prefLabel "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 P1433 Q93078400-F193AE6F-504A-4665-919E-8586E131A5DF @default.
- Q93078400 P1476 Q93078400-79E30E28-51FE-4F09-A5D0-A359DDFB03DB @default.
- Q93078400 P2093 Q93078400-260C4FFB-5F46-41FA-B687-0D84509A91C9 @default.
- Q93078400 P2093 Q93078400-683019B1-9E0E-43DA-9E39-70E0833DC056 @default.
- Q93078400 P2093 Q93078400-7EDBFC7A-DDFF-44E5-9F32-8952923AEC9D @default.
- Q93078400 P2093 Q93078400-893EB7AE-DFD5-4482-BB54-2F80F7B6E471 @default.
- Q93078400 P2093 Q93078400-EE299E31-DAD5-443C-9D67-8060A120CC12 @default.
- Q93078400 P304 Q93078400-ACD8034A-82D9-4B48-9BAF-983BB729B0C7 @default.
- Q93078400 P31 Q93078400-A8AABCDD-B2D9-4850-A2BD-486F9FF3978E @default.
- Q93078400 P356 Q93078400-92958B8C-1DBC-47F2-B357-B9B42F76EBFD @default.
- Q93078400 P478 Q93078400-730B6FEF-E0AE-4734-AB45-096FA057F325 @default.
- Q93078400 P577 Q93078400-402815A8-3760-4482-B708-F27B3DB13362 @default.
- Q93078400 P698 Q93078400-BB36389B-89B1-4C0C-B5C4-10B125205D5C @default.
- Q93078400 P921 Q93078400-BCD19F6B-BDAE-4C62-8E9B-D466C828E34A @default.
- Q93078400 P356 J.CANLET.2018.10.022 @default.
- Q93078400 P698 30429107 @default.
- Q93078400 P1433 Q326372 @default.
- Q93078400 P1476 "Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers" @default.
- Q93078400 P2093 "Feng Bi" @default.
- Q93078400 P2093 "Hongwei Xia" @default.
- Q93078400 P2093 "Qiulin Tang" @default.
- Q93078400 P2093 "Sheng Zhou" @default.
- Q93078400 P2093 "Xinyu Dai" @default.
- Q93078400 P304 "202-212" @default.
- Q93078400 P31 Q13442814 @default.
- Q93078400 P356 "10.1016/J.CANLET.2018.10.022" @default.
- Q93078400 P478 "442" @default.
- Q93078400 P577 "2018-10-26T00:00:00Z" @default.
- Q93078400 P698 "30429107" @default.
- Q93078400 P921 Q218507 @default.